Health Guidance Provision Infrastructure for Personalized Diabetes Management: The HealthDiab Solution

Health Guidance Provision Infrastructure for Personalized Diabetes Management: The HealthDiab Solution

Kostas Giokas, Dimitra Iliopoulou, Georgia Koutsouri, Dimitris Koutsouris
ISBN13: 9781466688285|ISBN10: 1466688289|EISBN13: 9781466688292
DOI: 10.4018/978-1-4666-8828-5.ch017
Cite Chapter Cite Chapter

MLA

Giokas, Kostas, et al. "Health Guidance Provision Infrastructure for Personalized Diabetes Management: The HealthDiab Solution." Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions, edited by Dimitrios I. Fotiadis, IGI Global, 2016, pp. 365-381. https://doi.org/10.4018/978-1-4666-8828-5.ch017

APA

Giokas, K., Iliopoulou, D., Koutsouri, G., & Koutsouris, D. (2016). Health Guidance Provision Infrastructure for Personalized Diabetes Management: The HealthDiab Solution. In D. Fotiadis (Ed.), Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions (pp. 365-381). IGI Global. https://doi.org/10.4018/978-1-4666-8828-5.ch017

Chicago

Giokas, Kostas, et al. "Health Guidance Provision Infrastructure for Personalized Diabetes Management: The HealthDiab Solution." In Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions, edited by Dimitrios I. Fotiadis, 365-381. Hershey, PA: IGI Global, 2016. https://doi.org/10.4018/978-1-4666-8828-5.ch017

Export Reference

Mendeley
Favorite

Abstract

Over the last 30 years, diabetes mellitus has changed from being seen as a relatively mild ailment associated with ageing and the elderly (‘just a touch of sugar') to one of the major contemporary causes of premature mortality and morbidity in most countries. HealthDiab aims at proposing the development of an innovative personal health management system overcoming the current limitations patients and their physicians find at managing the disease. The central element for such system will be patient's own daily health records, as base for the provision of personalised and real-time guidance in the treatment of diabetes. The proposed solution could easily be adopted as a commercial product by a company willing to bring an innovative and effective Personal Health Management technology platform into market. Such a platform could help reduce the risks for the patient by getting new comorbidities associated to their disease while helping decrease the billionaire public costs linked with health assistance in our European welfare states

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.